- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2025
- 197 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 242 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 175 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- August 2022
- 120 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2023
- 120 Pages
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- April 2023
- 160 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- February 2024
- 73 Pages
Europe, Africa, Middle East Europe, Africa, Middle East
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 112 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2024
- 96 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- May 2023
- 87 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- May 2022
- 57 Pages
Global
From €1901EUR$2,000USD£1,597GBP

The Nicotine Addiction Drugs market is a subset of the Addiction Disorders Drugs market, which includes medications used to treat substance use disorders. Nicotine Addiction Drugs are used to help people quit smoking and reduce their dependence on nicotine. These drugs work by reducing cravings and withdrawal symptoms, and can be used in combination with behavioral therapies. Common Nicotine Addiction Drugs include nicotine replacement therapy (NRT) products such as patches, gum, and lozenges, as well as non-nicotine medications such as bupropion and varenicline.
Some companies in the Nicotine Addiction Drugs market include GlaxoSmithKline, Pfizer, Johnson & Johnson, Novartis, and Mylan. Show Less Read more